2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Streptococcus Pneumoniae: new trials by email Literature Review of Streptococcus Pneumoniae trials Research Report on Streptococcus Pneumoniae
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About How a New Pneumococcal Vaccine Works in Adults PG4 vaccine in Buffer 1 with low dose PA-001, PG4 in Buffer 1 with low dose PA-002, PG4 in Buffer 1 with high dose PA-001 - Streptococcus Pneumoniae | Phase 1 | Active not recruiting | Pfizer | 380 | 2025-07-22 | 2026-06-22 |
| Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine Placebo, GEN-004 Low Dose, GEN-004 Low Dose + Adjuvant - Streptococcus Pneumoniae | Phase 1 | Completed | Genocea Biosciences, Inc. | 90 | 2013-11-01 | 2015-12-11 |
| Impact of the 7 Valent Pneumococcal Conjugate Vaccine (7vPCV) on Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Jordanian Infants 7 valent pneumococcal conjugate vaccine (7v-PCV) - Prevenar - Streptococcus Pneumoniae | Phase 1 / Phase 2 | Unknown | German-Jordanian University | 377 | 2009-05-01 | 2009-09-30 |
| Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine GSK2231395A, TwinrixTM - Haemophilus Influenzae, Streptococcus Pneumoniae | Phase 1 | Terminated | GlaxoSmithKline | 30 | 2009-03-12 | 2017-10-31 |
| Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults GSK2231395A, Engerix-B - Streptococcus Pneumoniae, Haemophilus Influenzae | Phase 1 | Completed | GlaxoSmithKline | 40 | 2009-01-08 | 2018-08-08 |
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Negative Bacterial Infections (2) · Infections (2) · Pasteurellaceae Infections (2)
Adjuvants, Pharmaceutic (1) · Engerix-B (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Sodium Chloride (1)
GlaxoSmithKline (2) · Genocea Biosciences, Inc. (1) · German-Jordanian University (1) · Pfizer (1)
United States (2) · Canada (1) · Jordan (1) · Sweden (1)
Adnan AL-lahham, PhD (1) · Mark Matson, MD (1)